0

Ceramide Inhibits L-type Calcium Channel Currents in GH3 Cells

C L Chik, B Li, E Karpinski, A K Ho

Mol Cell Endocrinol. 2004 Apr 15;218(1-2):175-83.

PMID: 15130522

Abstract:

In this study, we investigated the effect of ceramide on the L-type Ca2+ channel (L-channel) in GH3 cells. We found that C6-ceramide, but not C6-dihydroceramide, the inactive analogue, had an inhibitory effect on BayK 8644-stimulated GH release. Using patch clamp analysis, C6- and C2-ceramide, but not C6-dihydroceramide, were found to inhibit the L-channel current. Increasing intracellular ceramide level with sphingomyelinase also inhibited the L-channel current. The inhibitory effect of ceramide on the L-channel current was attenuated by calphostin C, a myristolated pseudosubstrate protein kinase C (PKC) inhibitor, and lavendustin A, a tyrosine kinase inhibitor. Combined treatment with lavendustin A and the myristolated PKC inhibitor blocked the effect of ceramide on the L-channel current. These results indicate that ceramide, a lipid messenger of the sphingomyelin pathway, is an important regulator of the L-channel in GH3 cells and both tyrosine kinase and PKC are involved in this effect of ceramide.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
IAR4243047 Dihydroceramide C6 Dihydroceramide C6 Price
qrcode